Zymergen, a Emeryville, CA-based company which uses microbes to manufacture high-value chemicals and new materials, raised $44m in Series A funding.
The round was led by Data Collective with participation from AME Cloud Ventures (Jerry Yang), Draper Fisher Jurvetson, HVF (Max Levchin), Eric Schmidt’s Innovation Endeavors, Obvious Ventures, True Ventures and Two Sigma Ventures.
Founded in 2013 by CEO Joshua Hoffman, Zymergen leverages biology to create essential chemicals and novel materials from clean, renewable sources. By applying its robotic automation, proprietary machine learning software, and computer analytics to the field of industrial microbiology, the company programs microbes to produce commercial molecules and offer them to several Fortune 100 companies.
FinSMEs
16/06/2015